| Literature DB >> 34938267 |
Jia Yu1, Yongzhe Gu1, Guilin Meng1, Xiaosa Zhu1, Wenxie Wang1, Xueyuan Liu1, Aiping Jin1.
Abstract
Background: Positional nystagmus induced by supine roll test is characteristic for diagnosing horizontal semicircular canal benign paroxysmal positional vertigo (HC-BPPV). In this study, we aimed to explore the value of nystagmus parameters in by supine roll test (SRT) as prognostic factors in HC-BPPV.Entities:
Keywords: benign paroxysmal positioning vertigo (BPPV); computer-controlled canalith repositioning procedure (CCRP); horizontal semicircular canal; nystagmus parameters; prognostic factors; supine roll test (SRT)
Year: 2021 PMID: 34938267 PMCID: PMC8687044 DOI: 10.3389/fneur.2021.790430
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Figure 1Supine roll test (SRT) mode in SRM-IV system for right horizontal semicircular canal benign paroxysmal positional vertigo (HC-BPPV). In the SRM-IV system SRT mode, each patient was placed in an automatic swivel chair as the starting position (A), shifted to the supine position (B), and then turned left 90° to the left lateral position (C), then turn right 180° to the right lateral position (D). Each action was completed at a speed of 90°/s. Once nystagmus was induced, its parameters were observed and recorded through video nystagmography, including latency, direction, time course, and a max slow phase velocity (SPV) (Figure 2). Then, the patient was slowly returned to the starting position until nystagmus completely disappeared (E).
Figure 2Nystagmus parameters in supine roll test (SRT).
Figure 3Flow chart of the study implementation. HC-BPPV, horizontal canal benign paroxysmal positional vertigo; PSM, propensity score matching.
Baseline characteristics of HC-BPPV resistant or cured groups.
|
|
|
| ||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| Age, y, mean (SD) | 56.8 ± 11.9 | 56.7 ± 13.6 | 0.962 | 56.8 ± 11.9 | 57.3 ± 12.9 | 0.753 |
|
| 0.103 | 0.518 | ||||
| Male | 24 (24.2%) | 231 (32.4%) | 24 (24.2%) | 28 (28.3%) | ||
| Female | 75 (75.8%) | 483 (67.6%) | 75 (75.8%) | 71 (71.7%) | ||
|
| ||||||
| SBP | 132.1 ± 15.2 | 131.4 ± 16.3 | 0.696 | 132.0 ± 15.1 | 130.4 ± 17.4 | 0.497 |
| DBP | 74.9 ± 9.1 | 76.6 ± 10.7 | 0.079 | 74.8 ± 9.0 | 74.6 ± 10.1 | 0.882 |
|
| 0.010 | 0.776 | ||||
| Right | 54 (54.5%) | 483 (67.6%) | 54 (54.5%) | 52 (52.5%) | ||
| Left | 45 (45.5%) | 231 (32.4%) | 45 (45.5%) | 47 (47.5%) | ||
|
| 0.639 | 0.810 | ||||
| Spring | 23 (23.2%) | 168 (23.5%) | 23 (23.2%) | 20 (20.2%) | ||
| Summer | 31 (31.3%) | 195 (27.3%) | 31 (31.3%) | 28 (28.3%) | ||
| Autumn | 19 (19.2%) | 176 (24.6%) | 19 (19.2%) | 24 (24.2%) | ||
| Winter | 26 (26.3%) | 175 (24.5%) | 26 (26.3%) | 27 (27.3%) | ||
P-values comparing persons in resistant or cured groups. HC-BPPV, horizontal canal benign paroxysmal positional vertigo; PSM, propensity score matching; SD, standard deviation; SBP, systolic blood pressure; DBP, diastolic blood pressure.
P <0.01.
Comparison of nystagmus parameters in SRT between HC-BPPV resistant or cured groups after PSM.
|
|
|
|
|
|
|---|---|---|---|---|
|
| ||||
| Latency | 0 (0, 4.0) | 0 (0, 4.1) | 0 (0, 4.0) | 0.773 |
| SPV | 8.3 (6.1, 12.5) | 7.9 (6.0, 11.7) | 9.2 (6.2, 13.5) | 0.444 |
|
| ||||
| Latency | 2.0 (0, 5.6) | 3.0 (0, 7.0) | 0 (0, 2.4) | <0.001 |
| SPV | 29.6 | 25.6 | 33.0 | 0.004 |
|
| ||||
| Latency | 0 (0, 3.0) | 1.0 (0, 4.0) | 0 (0, 1.6) | 0.001 |
| SPV | 12.1 | 9.9 | 13.4 | 0.005 |
| Latency difference | 0 (−1.0, 2.9) | 0.5 (−1.0, 5.0) | 0 (−0.9, 1.9) | 0.085 |
| SPV difference | 15.4 | 13.7 | 17.0 | 0.118 |
| SPV ratio | 2.2 (1.7, 3.1) | 2.2 (1.8, 3.2) | 2.2 (1.6, 3.0) | 0.753 |
P-values comparing persons in resistant or cured groups. SRT, supine roll test; HC-BPPV, horizontal canal benign paroxysmal positional vertigo; PSM, propensity score matching; SPV, slow phase velocity.
P <0.01;
P <0.001.
Univariate and multivariable analyses of nystagmus parameters in SRT between HC-BPPV resistant or cured groups after PSM.
|
|
|
| ||
|---|---|---|---|---|
|
|
|
|
| |
| Latency in supine position | 0.996 (0.910–1.089) | 0.928 | ||
| SPV in supine position | 0.980 (0.922–1.042) | 0.527 | ||
|
| 1.236 (1.117–1.369) |
| 1.231 (1.110–1.366) | <0.001 |
|
| 0.977 (0.958–0.997) |
| – | – |
|
| 1.120 (1.030–1.218) |
| – | – |
|
| 0.956 (0.920–0.993) |
| 0.957 (0.917–0.999) | 0.045 |
| Latency difference | 1.028 (0.976–1.083) | 0.298 | ||
| SPV difference | 0.983 (0.959–1.008) | 0.184 | ||
| SPV ratio | 1.042 (0.847–1.281) | 0.697 | ||
P-values comparing persons in resistant or cured groups. SRT, supine roll test; HC-BPPV, horizontal canal benign paroxysmal positional vertigo; PSM, propensity score matching; SPV, slow phase velocity.
P <0.05;
P <0.001. The bold and italics values indicate statistically significant difference.